Serious pneumococcal infections are a major global health problem and are vaccine-preventable.

Serious pneumococcal infections are a major global health problem and are vaccine-preventable.

PneumoADIP Activities

PneumoADIP Approach

PneumoADIP organizes its activities around three main areas of focus.

Surveillance and Research

Establishes the value of vaccination: first by demonstrating the burden of meningitis and pneumonia caused by pneumococcal bacteria and then by demonstrating the value of prevention through vaccination.
Read the Research and Surveillance Report>>

Communications and Advocacy

Ensures that the information about pneumococcal disease burden and vaccine value reaches key decision makers both in the countries in need of interventions and in donor countries.
Read the Five-Year Media Report>>

Vaccine Access and Implementation
Delivers the value of the vaccine by assuring that there is a predictable supply of
quality vaccine at an affordable price, an adequate system to deliver it to the
children who need it, and the financing to sustain its use.
Read the Strategic Demand Forecast History Report>>

 

PneumoACTION is a project of the International Vaccine Access Center
at Johns Hopkins Bloomberg School of Public Health